135 related articles for article (PubMed ID: 22805106)
1. Validation and interpretation of the Dutch version of the Multiple Sclerosis Neuropsychological Screening Questionnaire.
Sonder JM; Mokkink LB; van der Linden FA; Polman CH; Uitdehaag BM
J Neurol Sci; 2012 Sep; 320(1-2):91-6. PubMed ID: 22805106
[TBL] [Abstract][Full Text] [Related]
2. Relationship of the Multiple Sclerosis Neuropsychological Questionnaire (MSNQ) to functional, emotional, and neuropsychological outcomes.
O'Brien A; Gaudino-Goering E; Shawaryn M; Komaroff E; Moore NB; DeLuca J
Arch Clin Neuropsychol; 2007 Nov; 22(8):933-48. PubMed ID: 17851031
[TBL] [Abstract][Full Text] [Related]
3. Validation of the Multiple Sclerosis Neuropsychological Screening Questionnaire in Argentina.
Vanotti S; Benedict RH; Acion L; Cáceres F;
Mult Scler; 2009 Feb; 15(2):244-50. PubMed ID: 18845653
[TBL] [Abstract][Full Text] [Related]
4. Screening for multiple sclerosis cognitive impairment using a self-administered 15-item questionnaire.
Benedict RH; Munschauer F; Linn R; Miller C; Murphy E; Foley F; Jacobs L
Mult Scler; 2003 Feb; 9(1):95-101. PubMed ID: 12617275
[TBL] [Abstract][Full Text] [Related]
5. Validity of an Internet version of the Multiple Sclerosis Neuropsychological Questionnaire.
Akbar N; Honarmand K; Kou N; Levine B; Rector N; Feinstein A
Mult Scler; 2010 Dec; 16(12):1500-6. PubMed ID: 20813773
[TBL] [Abstract][Full Text] [Related]
6. Reliable screening for neuropsychological impairment in multiple sclerosis.
Benedict RH; Cox D; Thompson LL; Foley F; Weinstock-Guttman B; Munschauer F
Mult Scler; 2004 Dec; 10(6):675-8. PubMed ID: 15584493
[TBL] [Abstract][Full Text] [Related]
7. Repeated assessment of neuropsychological deficits in multiple sclerosis using the Symbol Digit Modalities Test and the MS Neuropsychological Screening Questionnaire.
Benedict RH; Duquin JA; Jurgensen S; Rudick RA; Feitcher J; Munschauer FE; Panzara MA; Weinstock-Guttman B
Mult Scler; 2008 Aug; 14(7):940-6. PubMed ID: 18573822
[TBL] [Abstract][Full Text] [Related]
8. The development and validation of a carer questionnaire to assess cognitive function in neuropsychiatric patients.
Randhawa S; Walterfang M; Miller K; Scholes A; Mocellin R; Velakoulis D
J Psychosom Res; 2007 Jul; 63(1):93-8. PubMed ID: 17586342
[TBL] [Abstract][Full Text] [Related]
9. Self-assessment of cognition in Multiple Sclerosis: the role of personality and anxiety.
Akbar N; Honarmand K; Feinstein A
Cogn Behav Neurol; 2011 Sep; 24(3):115-21. PubMed ID: 21904202
[TBL] [Abstract][Full Text] [Related]
10. Predicting neuropsychological abnormalities in multiple sclerosis.
Benedict RH; Zivadinov R
J Neurol Sci; 2006 Jun; 245(1-2):67-72. PubMed ID: 16626751
[TBL] [Abstract][Full Text] [Related]
11. Validity of the Italian multiple sclerosis neuropsychological screening questionnaire.
Migliore S; Landi D; Proietti F; D'Aurizio G; Squitieri F; Mataluni G; Nicoletti CG; Curcio G; Marfia GA
Neurol Sci; 2021 Nov; 42(11):4583-4589. PubMed ID: 33651198
[TBL] [Abstract][Full Text] [Related]
12. Proxy measurements in multiple sclerosis: agreement on different patient-reported outcome scales.
Sonder JM; Bosma LV; van der Linden FA; Knol DL; Polman CH; Uitdehaag BM
Mult Scler; 2012 Feb; 18(2):196-201. PubMed ID: 21908479
[TBL] [Abstract][Full Text] [Related]
13. Brief screening tool for mild cognitive impairment in older Japanese: validation of the Japanese version of the Montreal Cognitive Assessment.
Fujiwara Y; Suzuki H; Yasunaga M; Sugiyama M; Ijuin M; Sakuma N; Inagaki H; Iwasa H; Ura C; Yatomi N; Ishii K; Tokumaru AM; Homma A; Nasreddine Z; Shinkai S
Geriatr Gerontol Int; 2010 Jul; 10(3):225-32. PubMed ID: 20141536
[TBL] [Abstract][Full Text] [Related]
14. The clinical value of the patient-reported multiple sclerosis neuropsychological screening questionnaire.
Nauta IM; Balk LJ; Sonder JM; Hulst HE; Uitdehaag BM; Fasotti L; de Jong BA
Mult Scler; 2019 Oct; 25(11):1543-1546. PubMed ID: 29775164
[TBL] [Abstract][Full Text] [Related]
15. The validation of the Italian version of multiple sclerosis neuropsychological screening questionnaire in Huntington's disease.
Migliore S; D'Aurizio G; Ceccarelli C; Casella M; Curcio G; Squitieri F
Neurol Sci; 2023 Dec; 44(12):4343-4348. PubMed ID: 37432564
[TBL] [Abstract][Full Text] [Related]
16. Validation of the Spanish Version of the Addenbrooke's Cognitive Examination-Revised (ACE-R).
Torralva T; Roca M; Gleichgerrcht E; Bonifacio A; Raimondi C; Manes F
Neurologia; 2011; 26(6):351-6. PubMed ID: 21232827
[TBL] [Abstract][Full Text] [Related]
17. Interpreting patient/informant discrepancies of reported cognitive symptoms in MS.
Carone DA; Benedict RH; Munschauer FE; Fishman I; Weinstock-Guttman B
J Int Neuropsychol Soc; 2005 Sep; 11(5):574-83. PubMed ID: 16212684
[TBL] [Abstract][Full Text] [Related]
18. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
19. Validation of the Finnish version of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) and evaluation of the applicability of the Multiple Sclerosis Neuropsychological Questionnaire (MSNQ) and the Fatigue Scale for Motor and Cognitive Functions (FSMC).
Hämäläinen P; Leo V; Therman S; Ruutiainen J
Brain Behav; 2021 Jun; 11(6):e02087. PubMed ID: 33960700
[TBL] [Abstract][Full Text] [Related]
20. The Audio Recorded Cognitive Screen (ARCS) in patients with multiple sclerosis: a practical tool for multiple sclerosis clinics.
Lechner-Scott J; Kerr T; Spencer B; Agland S; Lydon A; Schofield PW
Mult Scler; 2010 Sep; 16(9):1126-33. PubMed ID: 20621944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
